These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 6370976)

  • 1. Multicenter double-blind comparison of nomifensine and imipramine for efficacy and safety in depressed outpatients.
    Bremner JD; Abrahams LM; Crupie JE; McCawley A; Proctor RC; Sathananthan GL
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):56-9. PubMed ID: 6370976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-blind comparative evaluation of the efficacy and safety of nomifensine, imipramine, and placebo in depressed geriatric outpatients.
    Merideth CH; Feighner JP; Hendrickson G
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):73-7. PubMed ID: 6370981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nomifensine vs. imipramine in depressed inpatients.
    Fann WE; Lyle FA; Higginbotham W
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):60-2. PubMed ID: 6370978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A two-center double-blind study of nomifensine, imipramine, and placebo in depressed geriatric outpatients.
    Cohn JB; Varga L; Lyford A
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):68-72. PubMed ID: 6370980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-blind placebo-controlled multicenter evaluation of the efficacy and safety of nomifensine in depressed outpatients.
    Goldstein BJ; Brauzer B; Kentsmith D; Rosenthal S; Charalampous KD
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):52-5. PubMed ID: 6370975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An overview of side effects and long-term experience with nomifensine from United States clinical trials.
    Yakabow AL; Hardiman S; Nash RJ
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):96-101. PubMed ID: 6370985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-blind comparison of the efficacy and safety of nomifensine maleate vs. placebo in depressed outpatients.
    Georgia EH
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):43-6. PubMed ID: 6232263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pooling 12 nomifensine studies for efficacy generalizability.
    Gillings D; Grizzle J; Koch G; Rickels K; Amara I; Donelan M; Hardiman S; Nash R; Sollecito W; Stager W
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):78-84. PubMed ID: 6370982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nomifensine in geriatric inpatients: a placebo-controlled study.
    Jansen W; Siegfried K
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):63-7. PubMed ID: 6370979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicenter placebo-controlled evaluation of nomifensine treatment in depressed outpatients.
    Feighner JP; Merideth CH; Claghorn JL
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):47-51. PubMed ID: 6370974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluoxetine in depressed patients: a comparison with imipramine.
    Bremner JD
    J Clin Psychiatry; 1984 Oct; 45(10):414-9. PubMed ID: 6384203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nomifensine in the treatment of depressed geriatric patients.
    Goldstein SE; Birnbom F; Laliberte R
    J Clin Psychiatry; 1982 Jul; 43(7):287-9. PubMed ID: 7045090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A double-blind comparison study of nomifensine and imipramine in treating depressed patients].
    Wang XJ
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1989 Apr; 22(2):73-6, 125. PubMed ID: 2791759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of alprazolam and imipramine for treatment of outpatient depression.
    Overall JE; Biggs J; Jacobs M; Holden K
    J Clin Psychiatry; 1987 Jan; 48(1):15-9. PubMed ID: 3542981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind placebo-controlled study of fluvoxamine and imipramine in depression.
    Dominguez RA; Goldstein BJ; Jacobson AF; Steinbook RM
    J Clin Psychiatry; 1985 Mar; 46(3):84-7. PubMed ID: 3918993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of fluoxetine, imipramine, and placebo in patients with major depressive disorder.
    Cohn JB; Wilcox C
    J Clin Psychiatry; 1985 Mar; 46(3 Pt 2):26-31. PubMed ID: 3882677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nomifensine, imipramine and placebo in depressed outpatients.
    Rickels K; Weise CC; Sandler K; Schless A; Zal M; Norstad N
    Int Pharmacopsychiatry; 1982; 17 Suppl 1():73-88. PubMed ID: 6752080
    [No Abstract]   [Full Text] [Related]  

  • 18. A 6-week, double-blind trial of paroxetine, imipramine, and placebo in depressed outpatients.
    Fabre LF
    J Clin Psychiatry; 1992 Feb; 53 Suppl():40-3. PubMed ID: 1531823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and tolerance of femoxetine and imipramine in the treatment of depressive states. A randomized, double-blind study.
    Suominen J; Tamminen T; Elosuo R; Manniche PM
    Pharmacopsychiatry; 1988 Sep; 21(5):238-44. PubMed ID: 3067246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of nomifensine in different depressive syndromes.
    Overall JE
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):85-8. PubMed ID: 6370983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.